Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 6.26
(4.86%)
CNY 6.26
(4.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 137.12 Million CNY | -4.4% |
| 2022 | 143.43 Million CNY | -17.11% |
| 2021 | 173.04 Million CNY | 44.15% |
| 2020 | 120.04 Million CNY | 53.34% |
| 2019 | 78.28 Million CNY | 0.0% |
| 2018 | - CNY | -100.0% |
| 2017 | 15 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 10 Million CNY | -54.55% |
| 2013 | 22 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 127.24 Million CNY | -7.2% |
| 2024 Q3 | 143.85 Million CNY | -6.35% |
| 2024 Q2 | 161.73 Million CNY | 27.1% |
| 2023 Q1 | 103.35 Million CNY | -27.94% |
| 2023 Q3 | 122.9 Million CNY | -8.32% |
| 2023 Q2 | 134.05 Million CNY | 29.7% |
| 2023 Q4 | 137.12 Million CNY | 11.57% |
| 2023 FY | 137.12 Million CNY | -4.4% |
| 2022 Q3 | 156.41 Million CNY | -6.57% |
| 2022 Q1 | 173.73 Million CNY | 0.4% |
| 2022 FY | 143.43 Million CNY | -17.11% |
| 2022 Q4 | 143.43 Million CNY | -8.3% |
| 2022 Q2 | 167.41 Million CNY | -3.64% |
| 2021 Q3 | 163.78 Million CNY | 1.3% |
| 2021 FY | 173.04 Million CNY | 44.15% |
| 2021 Q4 | 173.04 Million CNY | 5.66% |
| 2021 Q2 | 161.68 Million CNY | -1.08% |
| 2021 Q1 | 163.44 Million CNY | 36.15% |
| 2020 Q4 | 120.04 Million CNY | -28.67% |
| 2020 FY | 120.04 Million CNY | 53.34% |
| 2020 Q2 | 152.28 Million CNY | 54.94% |
| 2020 Q1 | 98.28 Million CNY | 25.55% |
| 2020 Q3 | 168.28 Million CNY | 10.51% |
| 2019 Q3 | 50 Million CNY | 0.0% |
| 2019 Q2 | 50 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 78.28 Million CNY | 0.0% |
| 2019 Q4 | 78.28 Million CNY | 56.58% |
| 2018 FY | - CNY | -100.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | -100.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | 15 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | 15 Million CNY | 0.0% |
| 2017 Q4 | 15 Million CNY | 0.0% |
| 2017 Q3 | 15 Million CNY | 0.0% |
| 2017 Q2 | 15 Million CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2014 FY | 10 Million CNY | -54.55% |
| 2013 FY | 22 Million CNY | 0.0% |